Ace shuttler PV Sindhu, on Wednesday, said her dream is to become World No 1 and she is trying to reach the numero uno spot.
The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.
Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga
So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.
Students who have received admission to foreign universities are struggling with unexpected delays, additional living costs and scarcity of vaccine supplies.
Once the patients are identified, the government will decide on the quantum of compensation in each case and then approach J&J for claim settlement.
Asserting that India is on track to vaccinate its entire adult population by December, top officials on Monday said a blueprint is in place to ensure a total supply of 187.2 crore doses by the year-end that would be enough for the country's 94 crore 18-plus population.
The Biden administration had been under pressure to send the excess COVID-19 vaccines with the US to nations like India, which are facing severe vaccine shortages.
The CEOs round table is expected to be attended by Apple chief Tim Cook, Walmart head Doug McMillon, Caterpillar's Jim Umpleby, Google head Sundar Pichai and Microsoft's Satya Nadella.
'At the current time, we should be vaccinating all those who are potentially going to get more severe illness, before we start vaccinating very young individuals.'
Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented effort to manufacture billions of doses.
Tech companies typically do lots of business overseas and book profits in low-tax jurisdictions.
Sanam Re is a moronic film, feels Sukanya Verma.
Of the 4.10 crore to be shared through COVAX, 1.40 crore will go to Latin America and the Caribbean nations and 1.60 crore to Asia.
Australia's medicines and medical devices regulator on Monday formally recognised India's Covaxin, a vaccine against the coronavirus as the country's border was reopened for the first time in nearly 20 months.
Currently, the country is using two 'made-in India' jabs -- Covishield and Covaxin -- to inoculate its billion-plus population and has administered 20 crore doses since launching the world's largest vaccination drive in mid-January. A third vaccine, Russian-made Sputnik V, has been approved by the government and is being used on a smaller scale at present.
More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.
Three entities are at the centre of this controversy: The Brazilian government, Bharat Biotech and a Singapore-based company called Madison Biotech.
Prime Minister Narendra Modi was welcomed by over 500 Indian-Americans who had gathered outside the Waldorf Astoria Hotel on Thursday.
Mumbai-based BabyChakra is among the four start-ups Google has shortlisted from India for the fifth batch of its mentorship programme
These vaccines have not yet been approved by the World Health Organization
Ratul Narain -- the entrepreneur behind Bempu -- tells Shobha Warrier that despite the challenges and frustrations, he is living his dream.
'The Union government has discouraged state and local governments from imposing restrictions on their own.' 'That advice should be withdrawn,' asserts Mihir S Sharma.
American CEOs expected to meet Modi on Sunday include Apple's Tim Cook, Walmart's Doug McMillon, Caterpillar's Jim Umpleby, Google's Sundar Pichai and Microsoft's Satya Nadella.
Reliance ADAG, Tech Mahindra among top recruiters at IIM-A
FMCG has been behaving unlike a defensive category in recent quarters.
The biggest spender was Tata Motors, with Rs 4,224.6 crore assigned under the R&D head.
While the November 2017 round of rate revisions saw mainly eating joints unwilling to pass on GST benefits, this time round, sanitary napkin makers, TV manufacturers and even paint companies have said passing on GST benefits is not a feasible exercise.
As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
A technical advisory group of the UN health agency which met on Tuesday has sought "additional clarifications" from Bharat Biotech for Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
The 30-share Sensex ended up 142 points at 29,462 and the 50-share Nifty gained 26 points to end at 8,895.
First acquisition under Sikka's plan of buying technologies for tomorrow
Weeks after the second wave peaked in many parts of the country, we are rapidly forgetting what happened to our hospitals, cautions Mihir S Sharma.
"Rather than putting pressure on the businesspeople of the Manufacturing Council & Strategy & Policy Forum, I am ending both. Thank you all!" Trump said in a tweet.
Sensex ended up 41 points at 29,136 and Nifty gained 4 pts to 8,809.
The vaccination rate needs to go up by three to four times, assert Ajay Shah and Amrita Agarwal.
5,565 contracts, valued at $201 billion are up for rebids across geographies and verticals by 2018.
'An influencer is expected to have upwards of 100,000 followers across various social media platforms of YouTube, Instagram, Facebook, Twitter etc,' points out brand strategist Ambi Parameswaran, founder, Brand-Building.com.
During a crisis situation, effective communication both internally and externally is one of the most important measures.
Walmart is rumoured to be looking to listing Flipkart in a few years. At that stage, we'll get a better sense of what's going on in retail, says Devangshu Datta.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances